KairoRx review

KairoRx’s most useful feature is a pricing page that explicitly separates first-month GLP-1 offers from continuing charges: compounded semaglutide is advertised from $49 for the first month and then $199 monthly, while tirzepatide is $99 initially and then $349. Branded Ozempic and Zepbound have a separate $65 monthly access fee with the drug purchased additionally. The menu also covers NAD+, sermorelin, testosterone, enclomiphene and ED medication. There is no separate membership fee, assessment is free, and treatment billing begins after clinical approval. The limitations are traceability and product-specific detail: the reviewed pages refer to provider and pharmacy networks without naming a dispensing partner or providing a full state list. Several therapies also vary by dose, so a broad from-price is not a complete prescription quote.

KairoRx’s About page calls the service a U.S. telehealth practice, but its legal terms more precisely describe KairoRx as a platform connecting patients with independent licensed providers and pharmacies, rather than a medical practice or pharmacy itself. The published Short Hills, New Jersey address is for correspondence, not a clinic patients can visit. Its treatment categories span weight management, hormones and performance, energy and recovery, and other longevity-oriented prescriptions. The clinical decision remains with a licensed provider, who can decline a requested therapy. A broad menu is a convenience for patients with several care questions, but it is not evidence that several prescriptions are appropriate together. The site discusses U.S.-registered pharmacies without naming the dispensing network on the reviewed About, pricing, FAQ or legal pages. Registration language should not be read as FDA approval of the products, and patients should request the actual pharmacy identity for their proposed prescription.

Patients browse a therapy and complete an online assessment. A U.S.-licensed provider reviews the history and determines whether the patient qualifies, with exclusion criteria applied. KairoRx says there is no charge just for the assessment or review and that a declined therapy incurs no treatment charge. Once a plan is approved, billing begins and the prescription is sent to a pharmacy for preparation and shipment. Continuing provider messaging is described as part of the model, while the exact visit format, laboratory requirements and follow-up schedule depend on the therapy. Testosterone care, an ED prescription and a weight-loss injection should not be assumed to use the same clinical pathway. The terms say availability may differ by state and is set out separately, so confirm the actual treatment and prescriber’s coverage rather than relying on the company’s U.S. identity. Ask for a clinical contact route and a plan for urgent side effects before the first shipment.

The public GLP-1 table lists semaglutide from $49 for the first month, then $199 monthly, and tirzepatide from $99, then $349 monthly. Ozempic and Zepbound are listed with a $65 monthly access fee plus medication cost. These branded access fees cannot be compared directly with a compounded price that includes the drug. Shipping is included, and KairoRx says there is no membership fee. It also warns that several therapies are priced by dose and that the individual treatment page contains the fuller detail. NAD+ injections start at $129 for the first month, injectable sermorelin at $149 for the first month, and their public summary does not establish the complete renewal cost. Other entries include NAD+ nasal spray from $125 monthly, sermorelin ODT from $99 monthly, testosterone from $129, enclomiphene from $89, sildenafil from $29 and tadalafil from $39. Those are separate starting offers, not a bundled menu. Plans recur until canceled through the account. The refund policy allows a request within 14 days of the first charge only if the pharmacy has not prepared the medication; after preparation or shipment, stopping the plan ends future cycles but does not refund the current one. A separate, explicitly purchased clinical consultation may have different refund rules once the review is performed.

The weight-loss section offers compounded semaglutide and tirzepatide as well as access to branded Ozempic and Zepbound. KairoRx states that compounded preparations are not FDA-approved and have not undergone the agency’s review for safety, efficacy or quality. That is a useful disclosure, but the prescriber still needs to explain the clinical reason for compounding and the identity of the pharmacy and formulation. The energy and recovery menu includes NAD+ injections and nasal spray, glutathione and MIC+B12. The hormone section includes injectable and oral-dissolving sermorelin, testosterone, enclomiphene and conventional ED drugs. These categories have different evidence, monitoring needs and prescribing restrictions; they should not inherit a safety or longevity conclusion from their position beside familiar GLP-1 brands. In particular, a nasal or oral compounded formulation is not interchangeable with an injection or an approved finished product. Compare the precise route, strength, expected benefit and follow-up plan before accepting a treatment based on its starting price.